Click to Share
 

Drug Development Press Releases

+ Alert
+ Feed
Exclusive News
Topics Locations Industries Dates

By Neurolixis, Inc.
Neurolixis issued a new US patent for treatment of Fragile X syndrome with NLX-101
12973824
By Wei Wang, PhD
IVIEW Therapeutics Inc. a clinical stage biotechnology company focusing on developing innovative ophthalmic therapeutics, organized a panel of dry eye experts and clinicians to gain key insights on dry eye treatment innovations.
By DeepThink Health
Ghosh Brings Three Decades of Life Sciences Experience to DeepThink Health

Page updated every 10 minutes
Trending
Most Viewed
Daily News


Like PRLog?
9K2K1K
Click to Share